Agfa HealthCare Launches DX-D Mobile Retrofit at ECR 2014

Agfa HealthCareAgfa HealthCare announces that it is launching the new DX-D Mobile Retrofit at ECR 2014. With this economical mobile direct radiography (DR) upgrade solution, facilities can get the most out of their existing X-ray investments by making the transition from analog film or computed radiography (CR) imaging to DR, allowing them to experience the benefits of cassette-less image capture and improved workflow and productivity.

Maximizing existing investments while improving workflow
DX-D Mobile Retrofit offers an easy and affordable way to migrate to direct digital imaging using the facility's existing X-ray equipment. Installation is quick, easy and non-invasive and does not change the unit's functionality.

DX-D Mobile Retrofit comes with the DX-D 30C and DX-D 35C wireless Cesium Iodide (CsI) detectors. These wireless panels may be shared with other fixed or mobile Agfa HealthCare DR solutions for further cost reduction.

The use of wireless DR detectors offers user convenience, immediate verification of positioning and image quality for faster transmission of the image to the picture archiving and communication system (PACS) in DICOM format.

DX-D Mobile Retrofit uses the NX workstation, so images have the same look and feel as Agfa HealthCare's CR solutions. It offers fast image previews and low cycle times, as well as seamless connectivity with the hospital's radiology information systems (RIS), PACS and hospital information systems (HIS).

Excellent image quality with the potential for dose reduction
DX-D Mobile Retrofit includes MUSICA advanced image processing, which has been specially adapted and tuned to further enhance the excellent DR image quality. Exam-independent, it provides consistent image quality and high contrast detail. CsI detectors provide the potential for dose reduction.

"With DX-D Mobile Retrofit, Agfa HealthCare is further extending its DR portfolio to offer facilities of all sizes, budgets, and imaging volumes an economical migration path to DR and all of its advantages," says Louis Kuitenbrouwer, Vice President Imaging at Agfa HealthCare. "Using our 'smart but simple' approach, it allows hospitals to do more with what they have, at an affordable cost, while benefiting from improved workflow and the excellent image quality Agfa HealthCare is known for."

About Agfa
The Agfa-Gevaert Group is one of the world's leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 3,091 million euro in 2012.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's. Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2012 were 1,212 million euro.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...